Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab

Kosuke Mizutani, Toshiki Ito, Kiyoshi Takahara, Ryosuke Ando, Takuma Ishihara, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake, Takuya Koie

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab'. Together they form a unique fingerprint.

Medicine & Life Sciences